SmallCap
CompaniesMapStatistics

이엔셀(주)

Venture Certified
Data Quality: 95/10

Basic Information


Unlisted

Company Name이엔셀(주)
English NameENCell Co., Ltd.
Business Reg. No.3608601147
CEO장종욱
Address서울특별시 송파구 송파대로 201 17층(송파테라타워2 A동)
Industry의학 및 약학 연구개발업
Industry Code70113
Main Products세포유전자치료제
EstablishedContact
Phone02-6205-8050
Websitewww.encellinc.com/
Regular Employees107persons
Corp. Reg. No.1101116693918

Investment Metrics


Market Cap
-
Op. Margin
-217.54%
ROE
-31.58%
Debt Ratio
15.73%

Certification Status


Venture Certified

Cert. History
벤처투자유형2018-06-21 ~ 2020-06-20201803004672018-06-21
벤처투자유형2020-06-21 ~ 2022-06-20202003005962018-06-21
벤처투자유형2022-06-21 ~ 2025-06-20202206090100322018-06-21
연구개발유형2025-06-21 ~ 2028-06-20202507290200172018-06-21

Financial Statements


3-Year Financial Data

Revenue CAGR -1.1%

Item202420232022
Revenue

72B

105B

74B

Operating Profit

-157B

-118B

-93B

Net Profit

-152B

-51B

-456B

Total Assets

557B

440B

547B

Total Liabilities

76B

60B

786B

Total Equity

482B

380B

-238B

Risk Indicators


3 Risk Indicators

Comparison Metrics


vs. 3-Year Avg.
Based on 2024
Revenue
72B

19.4%

vs. 3-Year Avg.: 89B
Operating Profit
-157B

48.9%

vs. 3-Year Avg.: -105B
Op. Margin
-217.5%

82.7%

vs. 3-Year Avg.: -119.1%
Debt Ratio
15.7%

110.0%

vs. 3-Year Avg.: -157.0%
ROE
-31.6%

135.5%

vs. 3-Year Avg.: 88.9%

Officers / Major Shareholders


Only CEO info available (unlisted company)
NamePositionRole
장종욱대표이사대표

Employment Status


NPS Subscribers

107persons

CEO장종욱
Est. Avg. Annual Salary

4,97510K

(41510K/mo)
Based on NPS rate 9.5%
Hired (12 mo)

+2persons

Left (12 mo)

-3persons

Net Change (12 mo)

-1persons

NPS Join Date

2018-04-05

Monthly Employee Trend
Hired
Left

Patent Status

Updated: 2026-02-25

No Data Contact

No patents found or data not yet available.

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status


Venture
Status

Cert. flags confirmed (details update after further collection)

Other Public Data


2 Additional Data Sources

{
  "address": "서울특별시 송파구 송파대로",
  "brno": "360860****",
  "cappedWarning": false,
  "companyName": "이엔셀주식회사",
  "estimatedAvgAnnualSalary": 49750524,
  "estimatedAvgMonthlySalary": 4145877,
  "fetchedAt": "2026-03-05T11:35:53.939Z",
  "industryCode": "730000",
  "industryName": "기타 인문 및 사회과학 연구개발업",
  "joinDate": "20180405",
  "last12MonthsHired": 2,
  "last12MonthsLeft": 3,
  "last12MonthsNetChange": -1,
  "leaveDate": null,
  "monthlyPensionAmount": 42142840,
  "monthlyTrend": [
    {
      "lostSubscribers": 3,
      "newSubscribers": 2,
      "yearMonth": null
    }
  ],
  "npsRateUsed": 0.095,
  "npsUpperCap": 6370000,
  "seq": "6790180",
  "status": "1",
  "styleCode": "1",
  "subscriberCount": 107,
  "turnoverMonths": 1
}

{
  "address": "서울 송파구",
  "ceo_name": "장종욱",
  "certificate": [
    {
      "cert_number": "20180300467",
      "changes": "",
      "disclosure_date": "2018-06-21",
      "first_cert_date": "2018-06-21",
      "no": "1",
      "type": "벤처투자유형",
      "valid_period": "2018-06-21 ~ 2020-06-20"
    },
    {
      "cert_number": "20200300596",
      "changes": "",
      "disclosure_date": "2020-05-21",
      "first_cert_date": "2018-06-21",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2020-06-21 ~ 2022-06-20"
    },
    {
      "cert_number": "20220609010032",
      "changes": "",
      "disclosure_date": "2022-06-09",
      "first_cert_date": "2018-06-21",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2022-06-21 ~ 2025-06-20"
    },
    {
      "cert_number": "20250729020017",
      "changes": "",
      "disclosure_date": "2025-07-29",
      "first_cert_date": "2018-06-21",
      "no": "4",
      "type": "연구개발유형",
      "valid_period": "2025-06-21 ~ 2028-06-20"
    }
  ],
  "company_name": "이엔셀 주식회사",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 122394000,
      "cost_of_sales": 6699827000,
      "current_assets": 31644291000,
      "current_liabilities": 74430247000,
      "gross_profit": 667535000,
      "net_income": -45566953000,
      "net_income_bs": -45566953000,
      "non_current_assets": 23102006000,
      "non_current_liabilities": 4151927000,
      "non_operating_expenses": 36815505000,
      "non_operating_income": 563994000,
      "operating_profit": -9315442000,
      "revenue": 7367362000,
      "sga_expenses": 9982977000,
      "total_assets": 54746297000,
      "total_equity": -23835877000,
      "total_liabilities": 78582174000
    },
    "2023": {
      "capital_stock": 4415688000,
      "cost_of_sales": 10883450000,
      "current_assets": 22928326000,
      "current_liabilities": 2742451000,
      "gross_profit": -357563000,
      "net_income": -5053520000,
      "net_income_bs": -5053520000,
      "non_current_assets": 21052825000,
      "non_current_liabilities": 3222368000,
      "non_operating_expenses": 1931753000,
      "non_operating_income": 8633290000,
      "operating_profit": -11755057000,
      "revenue": 10525887000,
      "sga_expenses": 11397494000,
      "total_assets": 43981151000,
      "total_equity": 38016332000,
      "total_liabilities": 5964819000
    },
    "2024": {
      "capital_stock": 5383089000,
      "cost_of_sales": 10194180000,
      "current_assets": 35544729000,
      "current_liabilities": 2688729000,
      "gross_profit": -2984862000,
      "net_income": -15209839000,
      "net_income_bs": -15209839000,
      "non_current_assets": 20200285000,
      "non_current_liabilities": 4888120000,
      "non_operating_expenses": 428198000,
      "non_operating_income": 901469000,
      "operating_profit": -15683110000,
      "revenue": 7209317000,
      "sga_expenses": 12698248000,
      "total_assets": 55745014000,
      "total_equity": 48168165000,
      "total_liabilities": 7576849000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "2,166,000,000",
      "changes": "2,166,000,000",
      "date": "2021-05-28"
    },
    {
      "amount": "1,500,000,000",
      "changes": "1,500,000,000",
      "date": "2021-05-28"
    },
    {
      "amount": "1,500,000,000",
      "changes": "1,500,000,000",
      "date": "2021-04-23"
    },
    {
      "amount": "1,500,000,000",
      "changes": "1,500,000,000",
      "date": "2021-04-23"
    },
    {
      "amount": "2,000,000,000",
      "changes": "2,000,000,000",
      "date": "2020-02-14"
    },
    {
      "amount": "666,000,000",
      "changes": "666,000,000",
      "date": "2020-02-14"
    },
    {
      "amount": "666,000,000",
      "changes": "666,000,000",
      "date": "2020-02-14"
    },
    {
      "amount": "300,000,000",
      "changes": "300,000,000",
      "date": "2018-05-29"
    }
  ],
  "main_products": "세포유전자치료제",
  "phone": "02-6205-****",
  "years": [
    2024,
    2023,
    2022
  ]
}

Data Sources


Data Quality: 95/10 | Primary Source: Venture System | Section Coverage: 8/8

Data Sources by Section
SectionSource:Status
Basic InfoDART
Collected
Financial StatementsVenture System
Collected
Investment MetricsVenture System
Collected
OfficersDART
Collected
EmploymentPublic Data
Collected
CertificationsPublic Data
Collected
PatentsKIPRIS
Collected
ProcurementG2B Procurement
Collected
Collected API Sources
APICollectedStatus
nps2026-03-05
Collected
DART Financial2026-02-26
Collected
G2B Procurement2026-02-25
Collected
KIPRIS Patents2026-02-25
Collected
Employment Insurance2026-02-25
Collected
HomeTax Business2026-02-25
Collected
Cert. Info2026-02-25
Collected
Venture System Detail2026-02-25
Collected